Literature DB >> 17113175

Linkage disequilibrium analysis of the CHRNA7 gene and its partially duplicated region in schizophrenia.

Yasuhide Iwata1, Mizuho Nakajima, Kazuo Yamada, Kazuhiko Nakamura, Yoshimoto Sekine, Kenji J Tsuchiya, Genichi Sugihara, Hideo Matsuzaki, Shiro Suda, Katsuaki Suzuki, Nori Takei, Norio Mori, Yoshimi Iwayama, Hitomi Takao, Takeo Yoshikawa, Brien Riley, Andrew Makoff, Pak Sham, Ronald Chen, David Collier.   

Abstract

Several previous studies have reported a significant linkage between markers in the alpha 7 nicotinic cholinergic receptor subunit (CHRNA7) gene and either schizophrenia or the P50 sensory gating deficit, a schizophrenia endophenotype. However, CHRFAM7A, a partially duplicated gene 1.6Mb upstream of the CHRNA7 gene, has complicated further genetic analysis. We genotyped 14 polymorphic markers throughout the full-length CHRNA7 gene and the duplicated region in 188 unrelated Han Chinese patients with schizophrenia and 188 controls. The duplicated regions were assessed by genotyping up- and down-stream polymorphic markers in the vicinity of each region and analyzing the linkage disequilibrium (LD) between each pair of markers. No evidence of risk variants for schizophrenia in either the CHRNA7 gene or the partially duplicated region was found in the LD analysis. A significant deviation from the Hardy-Weinberg equilibrium (HWE) was found only in the genotypic distribution of SNP9 (IVS4-1912) in patients (p=0.00829), but not in controls. In conclusion, our LD analysis did not reveal any association between schizophrenia in our Han Chinese population and the CHRNA7 gene or its partially duplicated region. However, we could not exclude the possibility of a weak genetic effect due to the small sample size. Analyses of larger samples and higher-density markers, particularly around SNP9 (IVS4-1912), are still needed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17113175     DOI: 10.1016/j.neures.2006.10.002

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  9 in total

1.  Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome.

Authors:  B W M van Bon; H C Mefford; B Menten; D A Koolen; A J Sharp; W M Nillesen; J W Innis; T J L de Ravel; C L Mercer; M Fichera; H Stewart; L E Connell; K Ounap; K Lachlan; B Castle; N Van der Aa; C van Ravenswaaij; M A Nobrega; C Serra-Juhé; I Simonic; N de Leeuw; R Pfundt; E M Bongers; C Baker; P Finnemore; S Huang; V K Maloney; J A Crolla; M van Kalmthout; M Elia; G Vandeweyer; J P Fryns; S Janssens; N Foulds; S Reitano; K Smith; S Parkel; B Loeys; C G Woods; A Oostra; F Speleman; A C Pereira; A Kurg; L Willatt; S J L Knight; J R Vermeesch; C Romano; J C Barber; G Mortier; L A Pérez-Jurado; F Kooy; H G Brunner; E E Eichler; T Kleefstra; B B A de Vries
Journal:  J Med Genet       Date:  2009-04-15       Impact factor: 6.318

2.  CHRFAM7A: a human-specific α7-nicotinic acetylcholine receptor gene shows differential responsiveness of human intestinal epithelial cells to LPS.

Authors:  Xitong Dang; Brian P Eliceiri; Andrew Baird; Todd W Costantini
Journal:  FASEB J       Date:  2015-02-13       Impact factor: 5.191

Review 3.  The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function.

Authors:  Melissa L Sinkus; Sharon Graw; Robert Freedman; Randal G Ross; Henry A Lester; Sherry Leonard
Journal:  Neuropharmacology       Date:  2015-02-19       Impact factor: 5.250

Review 4.  CHRFAM7A, a human-specific and partially duplicated α7-nicotinic acetylcholine receptor gene with the potential to specify a human-specific inflammatory response to injury.

Authors:  Todd W Costantini; Xitong Dang; Raul Coimbra; Brian P Eliceiri; Andrew Baird
Journal:  J Leukoc Biol       Date:  2014-12-03       Impact factor: 4.962

5.  Genetic Association Study of the Alpha 7 Nicotinic Receptor (CHRNA7) with the Development of Schizophrenia and Bipolar Disorder in Korean Population.

Authors:  Eun-Jeong Joo; Kyu Young Lee; Hyun Sook Kim; Se Hyun Kim; Yong Min Ahn; Yong Sik Kim
Journal:  Psychiatry Investig       Date:  2010-07-12       Impact factor: 2.505

6.  Meta-analyses of 10 polymorphisms associated with the risk of schizophrenia.

Authors:  Dongjun Dai; Yunliang Wang; Jiaojiao Yuan; Xingyu Zhou; Danjie Jiang; Jinfeng Li; Yuzheng Zhang; Honglei Yin; Shiwei Duan
Journal:  Biomed Rep       Date:  2014-06-30

Review 7.  Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia?

Authors:  S Bender; M Weisbrod; F Resch
Journal:  J Neural Transm (Vienna)       Date:  2007-05-21       Impact factor: 3.575

8.  Association of the Nicotinic Receptor α7 Subunit Gene (CHRNA7) with Schizophrenia and Visual Backward Masking.

Authors:  George Bakanidze; Maya Roinishvili; Eka Chkonia; Werner Kitzrow; Sarina Richter; Konrad Neumann; Michael H Herzog; Andreas Brand; Imke Puls
Journal:  Front Psychiatry       Date:  2013-10-22       Impact factor: 4.157

Review 9.  The Human-Restricted Isoform of the α7 nAChR, CHRFAM7A: A Double-Edged Sword in Neurological and Inflammatory Disorders.

Authors:  Simona Di Lascio; Diego Fornasari; Roberta Benfante
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.